Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
As a group, research analysts predict that MaxCyte, Inc. will post -0.36 earnings per share for the current fiscal year.
Source: https://www.etfdailynews.com/2023/07/30/maxcyte-inc-nasdaqmxct-director-sells-23750-00-in-stock/
Despite having 125+ clinical programs, of which 16 are active in the clinic, MaxCyte has not yet been associated with any commercial drug.
While the technology broadly has broad implications for the future of humanity, as investors we can marvel at the business model that MaxCyte has developed.